xmlinkhub
Kaplan–Meier curves depicting overall survival (OS; a, b) and... | Download Scientific Diagram
Frontiers | Causes of Death and Conditional Survival of Renal Cell Carcinoma
Overall survival of 180 patients with metastatic renal cell carcinoma... | Download Scientific Diagram
Phase 3 Study Tests a New Combination Therapy for Metastatic Renal Cell Cancer – Consult QD
Cancers | Free Full-Text | Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors
Overall survival rates of 95 patients with metastatic renal cell... | Download Scientific Diagram
Overall survival in metastatic renal cell carcinoma patients after... | Download Scientific Diagram
Clinical characteristics and prognosis of patients with renal cell carcinoma and liver metastasis
Frontiers | Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma
Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A Propensity-Score Matching Analysis
Kaplan-Meier curve depicting the overall survival of 359 metastatic... | Download Scientific Diagram
Duration of First-line Treatment with Molecular Targeted-Therapy Is a Prognostic Factor in Metastatic Renal Cell Carcinoma | Anticancer Research
Personalized Management of Advanced Kidney Cancer | American Society of Clinical Oncology Educational Book
Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram
Frontiers | Do Metastatic Kidney Cancer Patients Benefit From Cytoreductive Nephrectomy? A Real-World Retrospective Study From the SEER Database
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial - The Lancet Oncology
Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib | NEJM
Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies | British Journal of Cancer
JCM | Free Full-Text | Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
Overall survival of 124 patients who initially received cytokines... | Download Scientific Diagram
EAU 2021: Evolving Landscape of First-Line Systemic Treatment in Metastatic Renal Cell Carcinoma
Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program | Journal for ImmunoTherapy of Cancer
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology
Renal Cell Cancer Treatment (PDQ®)–Health Professional Version - NCI
